be_ixf;ym_202205 d_19; ct_50

Select Page

Latest Insights on NTLA

Gene Editors Turn It Off and On IT Crowd Meme Simmer-Down Sunday: 1 Biotech Breakfast, Coming Right Up
by Joseph Hargett February 6, 2022 Great Stuff
Comfy Like An Old Pair Of Genes Good morning, all ye Great Ones! Sunday brunch time is upon us once again, and this time, I hope you brought your appetites for weird science. Ugh, why is it always about food with you people? Quiet, you. ‘Twas just a few weeks ago that we gorged ourselves […]
market moves short-term trading BIG Market Moves Mean BIG Opportunities When the market moves this much, day trading has the potential to be lucrative.
gene editing biotech This Gene-Editing Stock Doubled in 3 Days Gene editing aims to cure diseases by replacing faulty genes with the healthy variant. That means no more monthly trips to the doctor.
Weird science Intellia therapeutics biotech meme small Intellia-gent Investing, Tesla’s Not-A-Recall & Binance Schminance
by Joseph Hargett June 28, 2021 Great Stuff
Wall Street’s Weird Science ♫ From my heart and from my hand, why don’t people understand … my intentions? ♫ Great Ones, did you see what happened in the biotech market today? Holy cow … it was poetry in motion. Intellia Therapeutics (Nasdaq: ) skyrocketed more than 50% after early trial data showed the company’s […]
Name Brands in Technology Name Brand Tech Stocks Are More Profitable for Your Portfolio Name brands are struggling to keep consumers’ loyalty. People opt for store or private-label brands that offer the same, if not better, quality than name brands at a better price. But there’s one sector where name brands still drive sales and revenue. Charles Mizrahi sees huge gains coming from name brands in this industry. (6-minute read)

Newsletter Sign Up

Sponsored

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“I found Profits Unlimited in Summer 2016. Starting with about $20,000, I began following your recommendations and did my own thing as well. Four years later, I am happy to report my portfolio is now in the six figures."

- Andrew

"I went all in with $310,000 and a year later, my portfolio was at $425,000. This I would have never accomplished with mutual funds, I will be following your research for the rest of my life thank you Paul and the team."

- Karl A.

“Looks like I have finally found the right person to learn and grow from.”

- James

Share This